Primary sclerosing cholangitis: A review and update

James H. Tabibian, Christopher L. Bowlus

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibro-obliterative inflammation of the bile ducts. In a clinically significant proportion of patients, PSC progresses to cirrhosis, end-stage liver disease, and/or hepatobiliary cancer, though the disease course can be highly variable. Despite clinical trials of numerous pharmacotherapies over several decades, safe and effective medical therapy remains to be established. Liver transplantation is an option for select patients with severe complications of PSC, and its outcomes are generally favorable. Periodic surveillance testing for pre-as well as post-transplant patients is a cornerstone of preventive care and health maintenance. Here we provide an overview of PSC, including its epidemiology, etiopathogenesis, clinical features, associated disorders, surveillance, and emerging potential therapies.

Original languageEnglish (US)
Pages (from-to)221-230
Number of pages10
JournalLiver Research
Volume1
Issue number4
DOIs
StatePublished - Dec 2017

Fingerprint

Sclerosing Cholangitis
Preventive Health Services
End Stage Liver Disease
Cholestasis
Bile Ducts
Liver Transplantation
Liver Diseases
Epidemiology
Fibrosis
Clinical Trials
Inflammation
Transplants
Drug Therapy
Therapeutics
Neoplasms

Keywords

  • Bile duct diseases
  • Cholangiocarcinoma
  • Cholangiography
  • Cholestasis
  • Magnetic resonance imaging
  • Natural history
  • Primary sclerosing cholangitis (PSC)

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Primary sclerosing cholangitis : A review and update. / Tabibian, James H.; Bowlus, Christopher L.

In: Liver Research, Vol. 1, No. 4, 12.2017, p. 221-230.

Research output: Contribution to journalReview article

Tabibian, James H. ; Bowlus, Christopher L. / Primary sclerosing cholangitis : A review and update. In: Liver Research. 2017 ; Vol. 1, No. 4. pp. 221-230.
@article{25007a327b754987bbd554eb1ceacc4f,
title = "Primary sclerosing cholangitis: A review and update",
abstract = "Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibro-obliterative inflammation of the bile ducts. In a clinically significant proportion of patients, PSC progresses to cirrhosis, end-stage liver disease, and/or hepatobiliary cancer, though the disease course can be highly variable. Despite clinical trials of numerous pharmacotherapies over several decades, safe and effective medical therapy remains to be established. Liver transplantation is an option for select patients with severe complications of PSC, and its outcomes are generally favorable. Periodic surveillance testing for pre-as well as post-transplant patients is a cornerstone of preventive care and health maintenance. Here we provide an overview of PSC, including its epidemiology, etiopathogenesis, clinical features, associated disorders, surveillance, and emerging potential therapies.",
keywords = "Bile duct diseases, Cholangiocarcinoma, Cholangiography, Cholestasis, Magnetic resonance imaging, Natural history, Primary sclerosing cholangitis (PSC)",
author = "Tabibian, {James H.} and Bowlus, {Christopher L.}",
year = "2017",
month = "12",
doi = "10.1016/j.livres.2017.12.002",
language = "English (US)",
volume = "1",
pages = "221--230",
journal = "Liver Research",
issn = "2542-5684",
number = "4",

}

TY - JOUR

T1 - Primary sclerosing cholangitis

T2 - A review and update

AU - Tabibian, James H.

AU - Bowlus, Christopher L.

PY - 2017/12

Y1 - 2017/12

N2 - Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibro-obliterative inflammation of the bile ducts. In a clinically significant proportion of patients, PSC progresses to cirrhosis, end-stage liver disease, and/or hepatobiliary cancer, though the disease course can be highly variable. Despite clinical trials of numerous pharmacotherapies over several decades, safe and effective medical therapy remains to be established. Liver transplantation is an option for select patients with severe complications of PSC, and its outcomes are generally favorable. Periodic surveillance testing for pre-as well as post-transplant patients is a cornerstone of preventive care and health maintenance. Here we provide an overview of PSC, including its epidemiology, etiopathogenesis, clinical features, associated disorders, surveillance, and emerging potential therapies.

AB - Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibro-obliterative inflammation of the bile ducts. In a clinically significant proportion of patients, PSC progresses to cirrhosis, end-stage liver disease, and/or hepatobiliary cancer, though the disease course can be highly variable. Despite clinical trials of numerous pharmacotherapies over several decades, safe and effective medical therapy remains to be established. Liver transplantation is an option for select patients with severe complications of PSC, and its outcomes are generally favorable. Periodic surveillance testing for pre-as well as post-transplant patients is a cornerstone of preventive care and health maintenance. Here we provide an overview of PSC, including its epidemiology, etiopathogenesis, clinical features, associated disorders, surveillance, and emerging potential therapies.

KW - Bile duct diseases

KW - Cholangiocarcinoma

KW - Cholangiography

KW - Cholestasis

KW - Magnetic resonance imaging

KW - Natural history

KW - Primary sclerosing cholangitis (PSC)

UR - http://www.scopus.com/inward/record.url?scp=85049505124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049505124&partnerID=8YFLogxK

U2 - 10.1016/j.livres.2017.12.002

DO - 10.1016/j.livres.2017.12.002

M3 - Review article

AN - SCOPUS:85049505124

VL - 1

SP - 221

EP - 230

JO - Liver Research

JF - Liver Research

SN - 2542-5684

IS - 4

ER -